What Happened?
, -based FibroGen Appointed Mark Lonergan as Executive Director of External Manufacturing and Supply Chain Operations
Date of management change: September 01, 2022
, -based FibroGen Appointed Mark Lonergan as Executive Director of External Manufacturing and Supply Chain Operations
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Mark Lonergan is Executive Director of External Manufacturing and Supply Chain Operations at FibroGen. Previously, Mark held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Sinor Sunita, Page Taylor, Johnson Elaine, Scheibel Kevin, Gann Babette, Lu Colbert, Brady Brenda, Sims Chazz, Piskorz Cezary, Siculan Julie, Chaurasia Bina
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.